Role of podoplanin expression in squamous cell carcinoma of upper aerodigestive tract.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Histology and Histopathology

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.14670/HH-28.293PMID 23348382
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic significance of high podoplanin expression after chemoradiotherapy in esophageal squamous cell carcinoma patients

  2012cited by this paper
• Clinical significance of lymphatic and blood vessel invasion in oral tongue squamous cell carcinomas.

  2012cited by this paper
• The use of tobacco-free betel-quid in conjunction with alcohol/tobacco impacts early-onset age and carcinoma distribution for upper aerodigestive tract cancer.

  2011cited by this paper
• Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx

  2011cited by this paper
• Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti‐Aggrus/podoplanin antibodies

  2011cited by this paper
• High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.

  2011cited by this paper
• Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.

  2011cited by this paper
• Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma

  2010cited by this paper
• Podoplanin, a novel marker for seminoma: A comparison study evaluating immunohistochemical expression of podoplanin and OCT3/4.

  2010cited by this paper
• Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin.

  2010cited by this paper
• Podoplanin Associates with CD44 to Promote Directional Cell Migration

  2010cited by this paper
• Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation.

  2010cited by this paper
• Podoplanin Expression in Basal and Myoepithelial Cells: Utility and Potential Pitfalls

  2010cited by this paper
• Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas

  2010cited by this paper
• Podoplanin-Expressing Cells Derived From Bone Marrow Play a Crucial Role in Postnatal Lymphatic Neovascularization

  2010cited by this paper
• Tumor cell expression of podoplanin correlates with nodal metastasis in esophageal squamous cell carcinoma.

  2009cited by this paper
• Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.

  2008cited by this paper
• Diagnostic implications of podoplanin expression in peripheral nerve sheath neoplasms.

  2008cited by this paper
• Podoplanin is a novel fos target gene in skin carcinogenesis.

  2008cited by this paper
• Selective loss of podoplanin protein expression accompanies proteinuria and precedes alterations in podocyte morphology in a spontaneous proteinuric rat model.

  2008cited by this paper
• The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients.

  2008cited by this paper
• T1alpha/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells.

  2008cited by this paper
• Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy.

  2008cited by this paper
• Podoplanin (D2-40) is a novel marker for follicular dendritic cell tumors.

  2007cited by this paper
• Involvement of the Snake Toxin Receptor CLEC-2, in Podoplanin-mediated Platelet Activation, by Cancer Cells*♦

  2007cited by this paper
• Tumorigenesis and Neoplastic Progression The Platelet Aggregation-Inducing Factor Aggrus / Podoplanin Promotes Pulmonary Metastasis

  2007cited by this paper
• Lymphatic Microvessel Density is an Independent Prognostic Factor in Colorectal Cancer

  2007cited by this paper
• Lateral peritumoral lymphatic vessel invasion can predict lymph node metastasis in esophageal squamous cell carcinoma

  2007cited by this paper
• Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma.

  2007cited by this paper
• Molecular analysis of the pathophysiological binding of the platelet aggregation‐inducing factor podoplanin to the C‐type lectin‐like receptor CLEC‐2

  2007cited by this paper
• Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression

  2006cited by this paper
• Podoplanin: A Novel Diagnostic Immunohistochemical Marker

  2006cited by this paper
• Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain.

  2006cited by this paper
• The potential role of podoplanin in tumour invasion

  2006cited by this paper
• Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton.

  2006cited by this paper
• Overexpression of podoplanin in oral cancer and its association with poor clinical outcome

  2006cited by this paper
• Podoplanin is expressed in subsets of tumors of the central nervous system

  2006cited by this paper
• Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition

  2006cited by this paper
• Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix

  2005cited by this paper
• Characterization of human PA2.26 antigen (T1α–2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas

  2005cited by this paper
• Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.

  2005cited by this paper
• Podoplanin as a marker for mesothelioma

  2005cited by this paper
• Systemic treatment for oesophageal cancer.

  2005cited by this paper
• Systemic treatment of oesophageal cancer

  2004cited by this paper
• T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema

  2003cited by this paper
• Molecular Identification of Aggrus/T1α as a Platelet Aggregation-inducing Factor Expressed in Colorectal Tumors*

  2003cited by this paper
• A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors

  2002cited by this paper
• Platelets and cancer.

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Putting tumours in context

  2001cited by this paper
• Experience in the treatment of synchronous and metachronous carcinoma of the oesophagus and the head and neck

  2000cited by this paper
• Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.

  1999cited by this paper
• Lysis of tumor cells by natural killer cells in mice is impeded by platelets.

  1999cited by this paper
• Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes.

  1999cited by this paper
• Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.

  1997cited by this paper
• Characterization of platelet aggregation induced by the human melanoma cell line HMV-I: roles of heparin, plasma adhesive proteins, and tumor cell membrane proteins.

  1991cited by this paper
• Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells.

  1989cited by this paper

• Histopathological Features of Cancer-Associated Venous Thromboembolism: Presence of Intrathrombus Cancer Cells and Prothrombotic Factors

  2022cites this paper
• Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts.

  2022cites this paper
• Near Infrared Photoimmunotherapy; A Review of Targets for Cancer Therapy

  2021cites this paper
• Near infrared photoimmunotherapy of cancer; possible clinical applications

  2021cites this paper
• Podoplanin : An Insight into its Role in Tumor Invasion and Metastasis

  2017cites this paper
• Podoplanin and SOX2 Expression in CIN 3–like Squamous Cell Carcinoma of the Cervix

  2017cites this paper
• SQUAMOUS CELL CARCINOMA OF THE ORAL TONGUE: STUDIES OF BIOMARKERS CONNECTED TO HUMAN PAPILLOMAVIRUS INFECTION, EPITHELIAL TO MESENCHYMAL TRANSITION AND LOCOREGIONAL METASTASIS

  2017cites this paper
• Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia

  2016cites this paper
• Phosphorylated mTOR expression correlates with podoplanin expression and high tumor grade in esophageal squamous cell carcinoma.

  2015cites this paper
• High sex determining region Y-box 2 (SOX2) expression correlates with absence of nodal metastasis in esophageal squamous cell carcinoma.

  2015influential citation
• Lymphatic endothelial cells derived from metastatic and non-metastatic lymph nodes of human colorectal cancer reveal phenotypic differences in culture.

  2015cites this paper
• Clinicopathology significance of podoplanin immunoreactivity in esophageal squamous cell carcinoma.

  2014cites this paper
• SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma

  2014cites this paper
• Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma.

  2014cites this paper